Our findings are consistent with previous studies [11–16], including a prospective study that also observed a protective association more than a decade after blood draw [11], providing further evidence that BAFF may be an etiologic risk factor of CLL. This evidence concerns the gene TNFSF13B and B-cell chronic lymphocytic leukemia.